| Revenue | SEK 0 | — |
| EBITDA | SEK -4K | -33% |
| Net profit | SEK -6M | -116% |
| Total assets | SEK 16,1M | -71% |
| Equity | SEK 10,1M | -74% |
| Employees | 0 | — |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | −3 | −3 | −3 | −3 | −4 | — | −3 | −4 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −3 | −3 | −3 | −4 | 0 | −3 | −4 |
| Net financials | — | — | — | — | — | — | 38 400 | −22 012 |
| Profit before tax | −3 | −3 | −3 | −3 | −4 | 0 | 38 397 | −5 974 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −3 | −3 | −3 | −4 | 0 | 38 397 | −5 974 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 78 | 75 | 72 | 69 | 65 | 65 | 54 462 | 16 058 |
| Equity | 78 | 75 | 72 | 69 | 65 | 65 | 38 462 | 10 088 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 16 000 | 5 970 |
| Total debt | — | — | — | — | — | — | 16 000 | 5 970 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RN Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Rosemed Holding AB | Company | 100.0% | 100.0% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Rolf Nicklas Kullberg | Chief Auditor | 0 companies |
| Said Richard Karroum | Board of Directors | 0 companies |
| Anders Leif Håkansson | Deputy Board Member | 0 companies |